Navigation Links
Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
Date:4/25/2012

SUNNYVALE, Calif., April 25, 2012 /PRNewswire/ -- Fujitsu Semiconductor America (FSA) and an impressive group of partner companies will highlight innovative radio-frequency identification (RFID) solutions using Fujitsu's Ferroelectric Random Access Memory (FRAM) technology at Interphex 2012 (booth 2430). Fujitsu and its partners will feature radiation-resistant FRAM RFID solutions suitable for medical and pharmaceutical applications where gamma sterilization is used. Interphex 2012 will be May 1-3 at the Javits Center in New York City.

(Logo: http://photos.prnewswire.com/prnh/20120412/SF85935LOGO-b)

Joining Fujitsu at Interphex will be Verigenics (http://www.verigenics.com), Vizinex RFID (http://www.vizinexrfid.com) and Toppan Printing Co., Ltd. (www.toppan.co.jp).

"Fujitsu's high-performance FRAM technology can track medical devices and supplies, even through the gamma sterilization process," said Tong Swan Pang, senior manager of marketing at Fujitsu Semiconductor America. "The partner companies joining us at Interphex 2012 have integrated Fujitsu's FRAM into their products to provide radiation-resistant, high-performance RFID solutions for use in the medical, bio-processing, and pharmaceutical industries."

For more information about the conference and Fujitsu's FRAM technology, please visit http://www.fujitsu.com/us/semiconductors/interphex2012.html.

How FRAM RFID Can Help Medical and Pharmaceutical Professionals

FRAM is a high-performance, low-power and non-volatile memory that combines the benefits of non-volatile memories (Flash and EEPROM) with high-speed RAM (SRAM and DRAM). Compared to other nonvolatile memories, key advantages of FRAM include a fast read / write speed (~150 nanoseconds), low power consumption (more than 200 times lower than EEPROM), and high endurance (10 billion read/write cycles). This tamper-resistant, secure memory is not affected by magnetic fields. Most important for medical and pharmaceutical applications, FRAM is radiation-resistant. FRAM data is protected against up to 50kGy gamma ray sterilization, more than twice the typical dosage used in medical applications.

Combined with RFID technologies, FRAM simplifies the task of assuring that vital medical and pharmaceutical products are safe. FRAM overcomes the serious limitation of conventional RFID tags that use EEPROM, a memory technology that can be compromised by small doses of radiation. Since the ferroelectric material at the heart of Fujitsu's FRAM technology is inherently radiation hardened, it can easily withstand the typical gamma ray sterilization. 

Fujitsu recently published a technical paper detailing how FRAM RFID can improve the medical sterilization process. It is available for free download from "EE Times": http://www.eetimes.com/electrical-engineers/education-training/tech-papers/4369829/How-FRAM-RFID-Improves-the-Medical-Sterilization-Process

The Fujitsu FerVID FRAM RFID Family

Fujitsu offers HF and UHF RFID products with embedded FRAM that outperforms conventional EEPROM/Flash based RFID chips and is better suited for medical and pharmaceutical applications. The FerVID FRAM RFID family, unlike conventional RFID tags, features high speed data transfer rate for both reading and writing over long distances.

The FerVID FRAM RFID family products are ISO/IEC15693, ISO/IEC 18000-3 or EPCglobal Class 1 Generation 2 compliant. Fujitsu offers wafers, sawn wafers or packaged chips. Derivatives with combined contactless and contact-based SPI interfaces are available. Fujitsu's RFID products come with capacities ranging from 256 Bytes to 64k Bytes of FRAM.

For more information about FRAM solutions available from Fujitsu, please visit http://us.fujitsu.com/semi/fram.

About Fujitsu Semiconductor America, Inc.

Fujitsu Semiconductor America, Inc. (FSA) is a leading designer and developer of innovative semiconductor products and solutions for new generations of consumer, communications, automotive and industrial products. FSA provides a comprehensive portfolio of high-quality, reliable semiconductor products and services throughout North and South America. Founded in 1979 and headquartered in Sunnyvale, California, Fujitsu Semiconductor America (formerly Fujitsu Microelectronics America) is a wholly owned subsidiary of Fujitsu Semiconductor Limited (FSL), Japan.

For product information, visit the company's website at http://us.fujitsu.com/semi, e-mail FSA_inquiry@us.fujitsu.com or call 1-800-866-8608. For company news and updates, connect with FSA on Twitter at http://twitter.com/FujitsuSemiUS or YouTube at http://www.youtube.com/FujitsuSemiUS.

All product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and subject to change without advance notice.

 

 


'/>"/>
SOURCE Fujitsu Semiconductor America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011
2. Blue Belt Technologies to Showcase Navio™ PFS System at CAOS UK 2012 Conference in Glasgow, UK
3. Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. MedPlasts Pessary Balloon Manufacture Showcases Multi-Function Technical Mastery
6. GenturaDx to Present at the Biotech Showcase Conference
7. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
8. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
9. Ikaria® to Present at Biotech Showcase™ 2012
10. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
11. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
(Date:2/23/2017)... -- Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden ... Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... York , February 23, 2017 ... arising from increasing caseload for varicose veins in their ... the globe are prompting the adoption of endovenous laser ... on global endovenous laser therapy market, published ... aftereffects of lifestyle choices and consequences of obesity have ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s ... of his paramedic experiences. Schanssema describes the tragedies he saw, as well as his ... them. , Schanssema, initially unsure of the career path he wanted to take, found ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating ... Me Beyond What You See” body image mannequin art competition. Selected from 15 submissions ... and the winner revealed at the 31st annual iaedp Symposium, March 22 – 26 ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... , ... The 89th Academy Awards will be celebrated this weekend, which means ... Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the ... Center for American Progress (CAP), for its report, Lessons From State Performance on NAEP: ...
(Date:2/23/2017)... ... ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be appearing ... which will begin airing on February 24, 2017. The show chronicles the weight loss ... television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted for ...
Breaking Medicine News(10 mins):